Rigel Pharmaceuticals (RIGL) Accumulated Depreciation & Amortization: 2011-2024
- Rigel Pharmaceuticals' Accumulated Depreciation & Amortization fell 84.68% to $261,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $27.3 million, marking a year-over-year decrease of 32.93%. This contributed to the annual value of $100,000 for FY2024, which is 50.00% down from last year.
- Per Rigel Pharmaceuticals' latest filing, its Accumulated Depreciation & Amortization stood at $261,000 for Q4 2024, which was down 84.68% from $1.7 million recorded in Q4 2023.
- In the past 5 years, Rigel Pharmaceuticals' Accumulated Depreciation & Amortization registered a high of $14.6 million during Q4 2021, and its lowest value of $261,000 during Q4 2024.
- For the 3-year period, Rigel Pharmaceuticals' Accumulated Depreciation & Amortization averaged around $4.3 million, with its median value being $1.7 million (2023).
- Per our database at Business Quant, Rigel Pharmaceuticals' Accumulated Depreciation & Amortization climbed by 6.40% in 2021 and then crashed by 84.68% in 2024.
- Rigel Pharmaceuticals' Accumulated Depreciation & Amortization (Quarterly) stood at $13.7 million in 2020, then rose by 6.40% to $14.6 million in 2021, then fell by 25.73% to $10.8 million in 2022, then slumped by 84.23% to $1.7 million in 2023, then slumped by 84.68% to $261,000 in 2024.
- Its last three reported values are $261,000 in Q4 2024, $1.7 million for Q4 2023, and $10.8 million during Q4 2022.
